South Korea’s Kyungdong Pharmaceutical plans to set up drug production in Kazakhstan.
As part of President Kassym-Jomart Tokayev’s visit to South Korea, Kazakhstan’s Ministry of Healthcare signed a memorandum of understanding with Kyungdong Pharmaceutical.
The memorandum provides for the transfer of advanced medical technologies, contract manufacturing of medicines and the phased launch of a joint venture to produce medicines in Kazakhstan.
Kazakhstan’s Minister of Healthcare Akmaral Alnazarova held talks with Kyungdong Pharmaceutical CEO Kim Kyung-hoon.
The parties discussed prospects for establishing drug production in Kazakhstan, technology transfer, contract manufacturing and the joint implementation of investment projects.
Kyungdong Pharmaceutical is a South Korean pharmaceutical company founded in 1975. It develops, manufactures and sells a wide range of medicines, including prescription and over-the-counter drugs, as well as active pharmaceutical ingredients.
The ministry noted that Kazakhstan’s pharmaceutical market reached $2.5 billion in 2025, while investment in pharmaceutical manufacturing totaled $142.8 million and exports reached $84 million.
